loading page

Transcatheter aortic valve implantation during the COVID-19 pandemic: clinical expert opinion and consensus statement for Asia.
  • +15
  • Edgar Tay,
  • Kentaro Hayashid,
  • Mao Chen,
  • Wei Hsien Yin,
  • Duk Woo Park,
  • Ashok Seth,
  • Hsien Li Kao,
  • Mao Shin Lin,
  • Kay Woon Ho,
  • Wacin Buddhari,
  • Mann Chandavimol,
  • Fabio Enriques Posas,
  • Nguyen Ngoc Quang,
  • William Kok-Fai Kong,
  • Rosli Mohd Ali,
  • Jimmy Hon,
  • Doni Firman,
  • Michael Lee
Edgar Tay
National University Heart Centre

Corresponding Author:[email protected]

Author Profile
Kentaro Hayashid
Keio University
Author Profile
Mao Chen
West China Hospital of Medicine
Author Profile
Wei Hsien Yin
Cheng Hsin General Hospital
Author Profile
Duk Woo Park
Asan Medical Center
Author Profile
Ashok Seth
Fortis Escorts Heart Institute and Research Centre
Author Profile
Hsien Li Kao
National Taiwan University Hospital
Author Profile
Mao Shin Lin
National Taiwan University Hospital
Author Profile
Kay Woon Ho
National Heart Centre Singapore
Author Profile
Wacin Buddhari
King Chulalongkorn Memorial Hospital
Author Profile
Mann Chandavimol
Ramathibodi Hospital
Author Profile
Fabio Enriques Posas
St Luke's Medical Center
Author Profile
Nguyen Ngoc Quang
Hanoi Medical University
Author Profile
William Kok-Fai Kong
National University Heart Centre
Author Profile
Rosli Mohd Ali
Cardiac Vascular Sentral
Author Profile
Jimmy Hon
National University Hospital Singapore
Author Profile
Doni Firman
Universitas Indonesia Fakultas Kedokteran
Author Profile
Michael Lee
queen elizabeth hospital
Author Profile


Objectives The impact of the COVID 19 pandemic on the treatment of patient with aortic valve stenosis is unknown and there is uncertainty on the optimal strategies in managing these patients. Methods This study is supported and endorsed by the Asia Pacific Society of Interventional Cardiology. Due to the inability to have face to face discussions during the pandemic, an online survey was performed by inviting key opinion leaders ( cardiac surgeon/interventional cardiologist/echocardiologist) in the field of transcatheter aortic valve implantation (TAVI) in Asia to participate. The answers to a series of questions pertaining to the impact of COVID-19 on TAVI were collected and analyzed. These led subsequently to an expert consensus recommendations on the conduct of TAVI during the pandemic Results The COVID 19 pandemic had resulted in a 25% (10-80) reduction of case volume and 53% of operators required triaging to manage their patients with severe aortic stenosis. The two most important parameters used to triage were symptoms and valve area. Periprocedural changes included the introduction of teleconsultation, pre-procedure COVD 19 testing, optimization of pre-tests and catheterization laboratory set up. In addition, length of stay was reduced from a mean of 4.4 to 4 days. Conclusion The COVID-19 pandemic has impacted on the delivery of TAVI services to patients in Asia. This expert recommendations on best practices may be a useful to guide to help TAVI teams during this period until a COVID 19 vaccine becomes widely available
19 May 2020Submitted to Journal of Cardiac Surgery
20 May 2020Submission Checks Completed
20 May 2020Assigned to Editor
20 May 2020Reviewer(s) Assigned
20 May 2020Review(s) Completed, Editorial Evaluation Pending
20 May 2020Editorial Decision: Revise Minor
21 May 20201st Revision Received
23 May 2020Submission Checks Completed
23 May 2020Assigned to Editor
23 May 2020Reviewer(s) Assigned
23 May 2020Review(s) Completed, Editorial Evaluation Pending
23 May 2020Editorial Decision: Accept